web analytics
4.7 C
Tuesday, November 29, 2022

The Inside Scoop on Cannabis Strategic Ventures (OTCMKTS: NUGS)

Cannabis Strategic Ventures (OTCMKTS: NUGS) has been making an explosive move up in recent weeks off its base at $1.50 a share to recent highs well over $5 per share. Everyone remembers NUGS for the spectacular run it made starting in December of last years to a high of $7.13 in January of this year. A break over $7.13 would mean big things for NUGS shareholders.

NUGS is a great place to be right now; major beverage industry players are jockeying for position in the nascent cannabis infused beverage market. Canada’s legalization of recreational marijuana, which goes into effect next week, triggered Fortune 500 sized interest in the cannabis sector which up until this point had stayed on the sidelines. Now Corona Beer parent Constellation Brands has jumped in to the cannabis sector making a $4 billion investment. Coca-Cola is “eyeing” the CBD sector and Molson Coors Brewing Co. has announced a partnership to develop a non-alcoholic cannabis infused beverage for the Canadian market.

Cannabis Strategic Ventures (OTCMKTS: NUGS) is a Publicly Traded Corporation that acquires, incubates, develops,and partners with brands around the world to build category leaders within the cannabis and CBD space. The Company recently announced an increased commitment to cannabis sector brands and innovators through the development of a proprietary branding and partnership model for the fast-growing Industry. Over the coming months, the Company will continue to develop multiple proprietary brands as its primary investment focus.

NUGS is establishing a strategic brand portfolio that include Cannabidiol better known as CBD, one of the many compounds specifically found in the Cannabis plant. It is believed that CBD provides therapeutic effects, such as pain and stress relief, and, unlike THC, does not give the user a “high” feeling. According to recent estimates from the Hemp Business Journal, the CBD market is projected to grow to a $2.1 billion market by 2020.

Earlier this year NUGS signed a definitive agreement to acquire the Fitamins CBD brand. Under the terms of the agreement, Fitamins will be distributing their vitamin and hemp derived CBD formulations through their network of 600+ wholesalers catered to the Asian-American market. Also on August 22 the Company acquired The Asher House Pet CBD brand from The Asher House LLC. Under the terms of the brand acquisition agreement, Cannabis Strategic Ventures will acquire controlling interest in the Asher House Pet CBD line, a line of U.S. hemp derived cannabidiol (CBD) supplements for pets, which continues gaining national attention.

Through the acquisitions, the Company gained access to Fitamins’ network of more than 600 wholesalers that distribute products to the Asian-American market; while The Asher House Pet CBD is gaining national attentional for their cross-country road show promoting Pet Adoption and Pet CBD.

To Find out the inside Scoop on NUGS Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

In August NUGS announced a major common share restructuring. A total of 75.6 million shares cancelled, including 20 million from Chief Executive Officer, Simon Yu. Yu is cancelling 20 million shares of his personal holdings. Additionally, Cannabis Strategic Ventures consultants and associates are canceling an additional 55.6 million shares. In total, approximately 25% of the total shares are being cancelled via this action.

Last month NUGS and True Promise Beauty announce the development of LYXR, a new line of cannabidiol (CBD)-based luxury skin, hair and body products. LYXR products are developed from a line of hemp-derived phytocannabinoids and other natural ingredients that provide high-performing skin, hair and body topical solutions.

For LYXR’s inaugural product, Cannabis Strategic Ventures and True Promise Beauty have developed a facemask, which is made from a CBD isolate. CBD isolate is believed to have anti-inflammatory, analgesic, anti-oxidant properties that helps to regenerate cells, as well as prevent the formation of bad cells (anti-cell proliferation). Additional mask proprietary ingredients will provide hydrating and anti-aging/age prevention benefits. The LYXR product line will eventually include skin, hair and body products.

Cannabis Strategic Ventures recently completed a full audit for its fiscal year ending March 31, 2018. This completes the three-year audit required as part of becoming a fully reporting company. The Company will utilize the audit results to file future reports and disclosures with the SEC and move the Company to fully reporting status. NUGS will also use the fully reporting status to up-list to a higher OTC Markets tier.

On October 10 NUGS announced the appointment of Alan Tran to its board of directors.  Mr. Tran’s addition as a director is the first of a series of steps to be taken by the Company in preparation for an up-listing on its common shares to a national exchange.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a market valuation exceeding a billion dollars NUGS had $165k in the treasury and about $1.5 million of debt on the books as well as $220k in sales in 2018 up from $0 last year. While NUGA trades at an incredibly high market valuation most of the 308,793,451 shares issued and outstanding are 144 restricted. In fact NUGS only has 3,830,656 shares in the float which is a big reason this one makes such parabolic moves.NUGS has been making some big moves; they are developing a new line of cannabidiol (CBD)-based luxury skin, hair and body products with True Promise Beauty. The recent acquisitions of Fitamins and The Asher Hous gives the Company access to Fitamins’ network of more than 600 wholesalers that distribute products to the Asian-American market; while The Asher House Pet CBD is gaining national attentional for their cross-country road show promoting Pet Adoption and Pet CBD. We will be updating on NUGS when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with NUGS.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in NUGS either long or short and we have not been compensated for this article.

More articles


Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.